Empowered Funds »

Theravance Biopharma shares owned by Empowered Funds

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Empowered Funds from 13F filings

Historical chart of Empowered Funds investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Empowered Funds consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Empowered Funds

Quarter filed Position value Share count Share price at filing
2026-03-31 $900k 56k 16.23

More positions owned by Empowered Funds

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
Chevron Corporation (CVX)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl C (GOOG)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Ishares Tr Core Msci Intl (IDEV)

View all positions for Empowered Funds

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Capital Management
State Street Corporation
Acadian Asset Management
Two Sigma Investments
Geode Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co
UBS Group
Susquehanna International
Oasis Management

View all funds holding Theravance Biopharma